$PCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pacira BioSciences, Inc.. Get notifications about new insider transactions in Pacira BioSciences, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Sell | S | 46.95 | 900 | 42,255 | 2,950 | 3.9 K to 3 K (-23.38 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Sell | S | 46.95 | 1,000 | 46,950 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 46.95 | 1,136 | 53,335 | 1,717 | 2.9 K to 1.7 K (-39.82 %) |
| May 04 2016 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 51.54 | 70,000 | 3,607,800 | 70,000 | |
| May 04 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 51.54 | 40,000 | 2,061,600 | 40,000 | |
| Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 1,000 | 10,810 | 0 | |
| Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,000 | 27,960 | 3,000 | |
| Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.00 | 3,000 | 180,000 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
| Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 1,000 | 10,810 | 5,853 | 4.9 K to 5.9 K (+20.61 %) |
| Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,000 | 27,960 | 4,853 | 2.9 K to 4.9 K (+70.10 %) |
| Apr 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 25,000 | 137,250 | 60,610 | |
| Apr 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 64.62 | 6,350 | 410,337 | 285 | 6.6 K to 285 (-95.70 %) |
| Apr 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 63.97 | 18,650 | 1,193,041 | 6,635 | 25.3 K to 6.6 K (-73.76 %) |
| Apr 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 25,000 | 137,250 | 25,285 | 285 to 25.3 K (+8,771.93 %) |
| Feb 01 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Buy | P | 58.92 | 2,000 | 117,840 | 2,000 | 0 to 2 K |
| Jan 29 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Buy | P | 62.50 | 500 | 31,250 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Jan 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 15,000 | 24,150 | 70,695 | |
| Jan 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 64.46 | 4,392 | 283,108 | 285 | 4.7 K to 285 (-93.91 %) |
| Jan 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 63.69 | 9,608 | 611,934 | 4,677 | 14.3 K to 4.7 K (-67.26 %) |
| Jan 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 62.55 | 1,000 | 62,550 | 14,285 | 15.3 K to 14.3 K (-6.54 %) |
| Jan 19 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 15,000 | 24,150 | 15,285 | 285 to 15.3 K (+5,263.16 %) |
| Jan 14 2016 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Buy | P | 66.55 | 300 | 19,965 | 2,300 | 2 K to 2.3 K (+15.00 %) |
| Jan 14 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Buy | P | 66.00 | 1,000 | 66,000 | 1,000 | 0 to 1,000 |
| Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 3,000 | 32,430 | 1,000 | |
| Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.00 | 3,000 | 180,000 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
| Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 3,000 | 32,430 | 5,853 | 2.9 K to 5.9 K (+105.15 %) |
| Nov 05 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 55.34 | 40,000 | 2,213,600 | 40,000 | |
| Oct 19 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 85,695 | |
| Oct 19 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 38.49 | 600 | 23,094 | 176 | 776 to 176 (-77.32 %) |
| Oct 19 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 37.89 | 7,799 | 295,504 | 776 | 8.6 K to 776 (-90.95 %) |
| Oct 19 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 37.11 | 6,601 | 244,963 | 8,575 | 15.2 K to 8.6 K (-43.50 %) |
| Oct 19 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 15,000 | 24,150 | 15,176 | 176 to 15.2 K (+8,522.73 %) |
| Sep 14 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | P | 61.37 | 5,000 | 306,850 | 10,504 | 5.5 K to 10.5 K (+90.84 %) |
| Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 61.90 | 40,000 | 2,476,000 | 40,000 | |
| Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 3,000 | 32,430 | 4,000 | |
| Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.02 | 3,000 | 180,060 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
| Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 3,000 | 32,430 | 5,853 | 2.9 K to 5.9 K (+105.15 %) |
| Jul 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 100,695 | |
| Jul 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 67.78 | 15,000 | 1,016,700 | 176 | 15.2 K to 176 (-98.84 %) |
| Jul 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 15,000 | 24,150 | 15,176 | 176 to 15.2 K (+8,522.73 %) |
| Jul 15 2015 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 67.11 | 75,000 | 5,033,250 | 75,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 79.43 | 15,000 | 1,191,450 | 15,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 79.43 | 7,500 | 595,725 | 7,500 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,750 | 0 | 5,980 | 2.2 K to 6 K (+168.16 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 2,000 | 0 | 2,853 | 853 to 2.9 K (+234.47 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 2,000 | 0 | 4,645 | 2.6 K to 4.6 K (+75.61 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 2,000 | 0 | 20,692 | 18.7 K to 20.7 K (+10.70 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 2,000 | 0 | 3,850 | 1.9 K to 3.9 K (+108.11 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Apr 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 25,000 | 40,250 | 115,695 | |
| Apr 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 90.50 | 25,000 | 2,262,475 | 59 | 25.1 K to 59 (-99.76 %) |
| Apr 17 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 25,000 | 40,250 | 25,059 | 59 to 25.1 K (+42,372.88 %) |
| Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,500 | 34,950 | 5,000 | |
| Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 88.00 | 2,500 | 220,000 | 853 | 3.4 K to 853 (-74.56 %) |
| Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,500 | 34,950 | 3,353 | 853 to 3.4 K (+293.08 %) |
| Mar 19 2015 | PCRX | Pacira Pharmaceuti ... | Markvicka Taunia | SVP, Chief Commerci ... | Option Exercise | M | 5.49 | 8,349 | 45,836 | 0 | |
| Mar 19 2015 | PCRX | Pacira Pharmaceuti ... | Markvicka Taunia | SVP, Chief Commerci ... | Buy | M | 5.49 | 8,349 | 45,836 | 8,579 | 230 to 8.6 K (+3,630.00 %) |
| Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Option Exercise | M | 10.34 | 5,000 | 51,700 | 25,000 | |
| Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Sell | S | 95.34 | 5,000 | 476,700 | 2,230 | 7.2 K to 2.2 K (-69.16 %) |
| Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Buy | M | 10.34 | 5,000 | 51,700 | 7,230 | 2.2 K to 7.2 K (+224.22 %) |
| Mar 17 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 93.83 | 1,000 | 93,830 | 18,692 | 17.7 K to 18.7 K (+5.65 %) |
| Mar 16 2015 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 29.90 | 3,000 | 89,700 | 0 | |
| Mar 16 2015 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Sell | S | 95.28 | 3,000 | 285,840 | 0 | 3 K to 0 (-100.00 %) |
| Mar 16 2015 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Buy | M | 29.90 | 3,000 | 89,700 | 3,000 | 0 to 3 K |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 38,250 | |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 112.91 | 1,700 | 191,947 | 5,230 | 6.9 K to 5.2 K (-24.53 %) |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 111.98 | 3,103 | 347,474 | 6,930 | 10 K to 6.9 K (-30.93 %) |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 111.11 | 5,904 | 655,993 | 10,033 | 15.9 K to 10 K (-37.05 %) |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 110.17 | 4,293 | 472,960 | 15,937 | 20.2 K to 15.9 K (-21.22 %) |
| Feb 09 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | M | 1.61 | 15,000 | 24,150 | 20,230 | 5.2 K to 20.2 K (+286.81 %) |
| Jan 20 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 140,695 | |
| Jan 20 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 98.74 | 1,600 | 157,984 | 1,267 | 2.9 K to 1.3 K (-55.81 %) |
| Jan 20 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 97.71 | 2,500 | 244,275 | 2,867 | 5.4 K to 2.9 K (-46.58 %) |
| Jan 20 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 97.30 | 10,900 | 1,060,570 | 5,367 | 16.3 K to 5.4 K (-67.01 %) |
| Jan 20 2015 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 15,000 | 24,150 | 16,267 | 1.3 K to 16.3 K (+1,183.90 %) |
| Jan 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,500 | 34,950 | 7,500 | |
| Jan 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 94.06 | 2,500 | 235,150 | 853 | 3.4 K to 853 (-74.56 %) |
| Jan 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,500 | 34,950 | 3,353 | 853 to 3.4 K (+293.08 %) |
| Dec 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 29.90 | 1,000 | 29,900 | 3,000 | |
| Dec 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Sell | S | 93.32 | 1,000 | 93,320 | 0 | 1,000 to 0 (-100.00 %) |
| Dec 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Buy | M | 29.90 | 1,000 | 29,900 | 1,000 | 0 to 1,000 |
| Dec 08 2014 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Buy | P | 94.54 | 2,645 | 250,058 | 2,645 | 0 to 2.6 K |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 53,250 | |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 90.33 | 200 | 18,066 | 5,000 | 5.2 K to 5 K (-3.85 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 89.56 | 800 | 71,648 | 5,200 | 6 K to 5.2 K (-13.33 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 87.65 | 3,100 | 271,715 | 6,000 | 9.1 K to 6 K (-34.07 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 86.99 | 8,600 | 748,114 | 9,100 | 17.7 K to 9.1 K (-48.59 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 86.13 | 2,300 | 198,099 | 17,700 | 20 K to 17.7 K (-11.50 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | M | 1.61 | 15,000 | 24,150 | 20,000 | 5 K to 20 K (+300.00 %) |
| Nov 12 2014 | PCRX | Pacira Pharmaceuti ... | Markvicka Taunia | SVP, Chief Commerci ... | Buy | P | 86.62 | 230 | 19,923 | 230 | 0 to 230 |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | G | 81.00 | 150,000 | 12,150,000 | 150,000 | |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | G | 81.00 | 150,000 | 12,150,000 | 0 | |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | G | 10.81 | 350,000 | 3,783,500 | 350,000 | |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | G | 10.81 | 350,000 | 3,783,500 | 0 | |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 170,960 | |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 101.20 | 1,198 | 121,238 | 1,208 | 2.4 K to 1.2 K (-49.79 %) |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 99.80 | 7,485 | 747,003 | 2,406 | 9.9 K to 2.4 K (-75.67 %) |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 99.05 | 5,417 | 536,554 | 9,891 | 15.3 K to 9.9 K (-35.39 %) |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 97.74 | 600 | 58,644 | 15,308 | 15.9 K to 15.3 K (-3.77 %) |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 96.60 | 300 | 28,980 | 15,908 | 16.2 K to 15.9 K (-1.85 %) |
| Oct 17 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 15,000 | 24,150 | 16,208 | 1.2 K to 16.2 K (+1,241.72 %) |
| Nov 04 2014 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 90.48 | 850 | 76,908 | 1,850 | 1,000 to 1.9 K (+85.00 %) |
| Oct 14 2014 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,500 | 34,950 | 10,000 | |
| Oct 14 2014 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 94.87 | 2,500 | 237,175 | 853 | 3.4 K to 853 (-74.56 %) |
| Oct 14 2014 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,500 | 34,950 | 3,353 | 853 to 3.4 K (+293.08 %) |
| Sep 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 29.90 | 1,000 | 29,900 | 4,000 | |
| Sep 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Sell | S | 96.40 | 1,000 | 96,400 | 0 | 1,000 to 0 (-100.00 %) |
| Sep 30 2014 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Buy | M | 29.90 | 1,000 | 29,900 | 1,000 | 0 to 1,000 |
| Sep 02 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 108.15 | 10,481 | 1,133,560 | 1,100,100 | 1.1 M to 1.1 M (-0.94 %) |
| Sep 02 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 108.06 | 11,013 | 1,190,097 | 1,110,581 | 1.1 M to 1.1 M (-0.98 %) |
| Aug 27 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 108.05 | 1,606 | 173,535 | 1,121,594 | 1.1 M to 1.1 M (-0.14 %) |
| Aug 27 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 108.11 | 24,207 | 2,617,016 | 1,123,200 | 1.1 M to 1.1 M (-2.11 %) |
| Aug 27 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 108.07 | 30,000 | 3,241,983 | 1,147,407 | 1.2 M to 1.1 M (-2.55 %) |
| Aug 12 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 101.82 | 37,786 | 3,847,491 | 1,177,407 | 1.2 M to 1.2 M (-3.11 %) |
| Aug 12 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 101.20 | 30,114 | 3,047,413 | 1,215,193 | 1.2 M to 1.2 M (-2.42 %) |
| Aug 12 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 101.00 | 82,100 | 8,292,108 | 1,245,307 | 1.3 M to 1.2 M (-6.18 %) |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Option Exercise | M | 1.61 | 6,134 | 9,876 | 68,250 | |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Option Exercise | M | 1.61 | 8,866 | 14,274 | 9,123 | |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 99.83 | 10,000 | 998,300 | 5,000 | 15 K to 5 K (-66.67 %) |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 99.22 | 5,000 | 496,100 | 15,000 | 20 K to 15 K (-25.00 %) |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | M | 1.61 | 6,134 | 9,876 | 20,000 | 13.9 K to 20 K (+44.24 %) |
| Aug 11 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | M | 1.61 | 8,866 | 14,274 | 13,866 | 5 K to 13.9 K (+177.32 %) |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 11.68 | 3,524 | 41,160 | 56,476 | |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 10.81 | 14,364 | 155,275 | 18,333 | |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 5.49 | 882 | 4,842 | 4,414 | |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 1.61 | 1,230 | 1,980 | 1,230 | |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 100.26 | 20,000 | 2,005,200 | 0 | 20 K to 0 (-100.00 %) |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 11.68 | 3,524 | 41,160 | 20,000 | 16.5 K to 20 K (+21.39 %) |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 10.81 | 14,364 | 155,275 | 16,476 | 2.1 K to 16.5 K (+680.11 %) |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 5.49 | 882 | 4,842 | 2,112 | 1.2 K to 2.1 K (+71.71 %) |
| Aug 08 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 1.61 | 1,230 | 1,980 | 1,230 | 0 to 1.2 K |
| Jul 16 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 155,695 | |
| Jul 16 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 88.23 | 1,000 | 88,230 | 1,208 | 2.2 K to 1.2 K (-45.29 %) |
| Jul 16 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 87.05 | 6,600 | 574,530 | 2,208 | 8.8 K to 2.2 K (-74.93 %) |
| Jul 16 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 86.28 | 7,400 | 638,472 | 8,808 | 16.2 K to 8.8 K (-45.66 %) |
| Jul 16 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 15,000 | 24,150 | 16,208 | 1.2 K to 16.2 K (+1,241.72 %) |
| Jul 15 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 10.81 | 7,303 | 78,945 | 32,697 | |
| Jul 15 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 5.49 | 20,237 | 111,101 | 5,296 | |
| Jul 15 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 1.61 | 2,460 | 3,961 | 2,460 | |
| Jul 15 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 87.58 | 2,107 | 184,531 | 0 | 2.1 K to 0 (-100.00 %) |